[Skip to Content]
[Skip to Content Landing]
Article
October 1970

Treatment of Behçet's Disease With Chlorambucil

Author Affiliations

Beirut, Lebanon
From the Department of Ophthalmology (Dr. Mamo) and Division of Hematology and Cancer Chemotherapy, Department of Medicine (Dr. Azzam), American University Hospital, Beirut, Lebanon.

Arch Ophthalmol. 1970;84(4):446-450. doi:10.1001/archopht.1970.00990040448008
Abstract

Eleven patients with Behçet's (and neuro-Behçet's) disease in the active and progressive stages were treated with chlorambucil (Leukeran). Follow-up varied between three weeks and 17 months. Results were favorable in all, and the drug was superior to other forms of treatment in that there was arrest and some amelioration of the disease.

References
1.
Sorsby A: Modern Ophthalmology . London, Butterworths, 1963, p 583.
2.
Mamo JG, Baghdassarian A:  Behçet's disease: A report of 28 cases . Arch Ophthal 71:4-14, 1964.Article
3.
Alema G, Bignami A:  Involvement of the nervous system in Behçet's disease , in Monacelli M, Nazzaro P (eds): Behçet's Disease . Basel, Switzerland, S Karger, 1966, p 56.
4.
Schotland DL, Wolf SM, White HH, et al:  Neurologic aspects of Behçet's disease . Amer J Med 34:544-553, 1963.Article
5.
Sezer FN:  The isolation of a virus as the cause of Behçet's disease . Amer J Ophthal 36:301-315, 1963.
6.
Evans AD, Pallis CA, Spillane JD:  Involvement of the nervous system in Behçet's syndrome: Report of three cases and isolation of virus . Lancet 2:349-353, 1957.Article
7.
Nakagawa Y, Shingu M:  Studies on the pathogenic agent of Behçet's disease: The isolation of Behçet's disease virus on the chorioallantois of developing chick embryos . J JAP Assoc Infect Dis 32:270, 1958.
8.
Mortada A, Imam ZEI:  Virus aetiology of Behçet's syndrome . Brit J Ophthal 48:250-259, 1964.Article
9.
Dowling GB, Dudgeon JA, Perkins ES:  Discussion on Behçet's disease . Proc Roy Soc Med 54:101-107, 1961.
10.
Hogan MJ, Zimmerman LE: Ophthalmic Pathology. Philadelphia, WB Saunders Co, 1962, p 387.
11.
Curth HO:  Recurrent genito-oral aphthosis and uveitis with hypopion (Behçet's syndrome) . Arch Derm Syph 54:179-196, 1946.Article
12.
Breslin JH:  Behçet's disease . Amer J Ophthal 53:132-136, 1962.
13.
Zeavin BH, King MJ, Gohd RS:  A case of Behçet's disease . Amer J Ophthal 41:55-60, 1956.
14.
Maumemee AE:  Ocular manifestations of collagen diseases . Arch Ophthal 56:557-562, 1956.Article
15.
Sulheim O, Dalgaard JB, Andersen SR:  Behçet's syndrome: Report of case with complete autopsy performed . Acta Path Microbiol Scand 45:145-158, 1959.Article
16.
Shikano S:  A histopathological study on Behçet's disease . Jap J Ophthal 5:54-67, 1961.
17.
Oshima Y, Shimizu Z, Yokohari R, et al:  Clinical studies on Behçet's syndrome . Ann Rheum Dis 22:36-45, 1963.Article
18.
Shimizu T, Katsuka Y, Schima Y:  Immunological studies on Behçet's syndrome . Ann Rheum Dis 24:494-500, 1965.Article
19.
Lehner T:  Behçet's syndrome and auto-immunity . Brit Med J 1:465-467, 1967.Article
20.
Wirostko E, Halbert SP:  Suppression of allergic uveitis by six-mercaptopurine . J Exp Med 116:653-663, 1962.Article
21.
Newell FW, Krill AE, Thomson A:  The treatment of uveitis with six-mercaptopurine . Amer J Ophthal 61:1250-1255, 1966.
22.
Wong VG, Hersh EM:  Methotrexate in the therapy of cyclitis . Trans Amer Acad Ophthal Otolaryng 69:279-293, 1965.
23.
Wong VG:  Methotrexate treatment of uveal disease . Amer J Med Sci 251:239-241, 1966.
24.
Wong VG, Hersh EM, McMaster PR:  Treatment of a presumed case of sympathetic ophthalmia with methotrexate . Arch Ophthal 76:66-76, 1966.Article
25.
Lazar M, Weiner M, Leopold I:  Treatment of uveitis with methotrexate . Amer J Ophthal 67:383-387, 1969.
26.
Newell FW, Krill AE:  Treatment of uveitis with azathioprine (Imuran) . Trans Ophthal Soc UK 87:499-511, 1967.
27.
Moore CE:  Sympathetic ophthalmitis treated with azathioprine . Brit J Ophthal 52:688-690, 1968.Article
28.
Wadia N, Williams E:  Behçet's syndrome with neurological complications . Brain 80:59-71, 1957.Article
29.
Sezer N:  Further investigations on the virus of Behçet's disease . Amer J Ophthal 41:41-55, 1956.
30.
Mamo JG:  The rate of visual loss in Behçet's disease . Arch Ophthal 84:451-452, 1970.Article
31.
Rosselet E, Saudan Y, Zenklusen G:  Les effets de l'azathioprine (Imuran) dans la maladie de Behçet . Ophthalmologica 156:218-226, 1968.Article
32.
Wong VG:  Immunosuppressive therapy of ocular inflammatory diseases . Arch Ophthal 81:628-637, 1969.Article
33.
Nazzaro P:  Cutaneous manifestations of Behçet's disease: Nonspecific skin sensitivity , in Monacelli M, Nazzaro P (eds): Behçet's disease . Basel, Switzerland, S Karger, 1966, p 23.
×